A meta-analysis of 13 clinical trials in AMI reported a highly significant 3.78% increase in LVEF for the MSCs-treated group compared to the control group ( Attar et al., 2021 ).
← all excerpts
Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease.
1
—
—